Carina Höring

Ms. Carina Höring

University of Regensburg, Department of Chemistry and Pharmacy
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
Verified
Journal Article
Open access
PDF file
Carina HöringCarina Höring
Carina Höring
USUlla Seibel-Ehlert
Ulla Seibel-Ehlert
KTKatharina Tropmann
Katharina Tropmann
LGLukas Grätz
Lukas Grätz
DMDenise Mönnich
Denise Mönnich
ASAndrea Strasser
Andrea Strasser
In drug discovery, assays with proximal readout are of great importance to study target-specific effects of potential drug candidates. In the field of G protein-coupled receptors (GPCRs), the determination of GPCR-G protein interactions and G protein activation by means of radiolabeled GTP analogs ([35S]GTPγS, [γ-32P]GTP) has widely been used for this purpose. Since we were repeatedly faced with insufficient quality of radiolabeled nucleotides, there was a requirement to implement a novel proximal functional assay for the routine characterization of putative histamine receptor ligands. We applied the split-NanoLuc to the four histamine receptor subtypes (H1R, H2R, H3R, H4R) and recently engineered minimal G (mini-G) proteins. Using this method, the functional response upon receptor activation was monitored in real-time and the four mini-G sensors were evaluated by investigating selected standard (inverse) agonists and antagonists. All potencies and efficacies of the studied ligands were in concordance with literature data. Further, we demonstrated a significant positive correlation of the signal amplitude and the mini-G protein expression level in the case of the H2R, but not for the H1R or the H3R. The pEC50 values of histamine obtained under different mini-G expression levels were consistent. Moreover, we obtained excellent dynamic ranges (Z’ factor) and the signal spans were improved for all receptor subtypes in comparison to the previously performed [35S]GTPγS binding assay.

Verified
Journal Article
Open access
PDF file
Carina HöringCarina Höring
Carina Höring
MCMarcus Conrad
Marcus Conrad
CSChristian A. Söldner
Christian A. Söldner
JWJinan Wang
Jinan Wang
HSHeinrich Sticht
Heinrich Sticht
YMYinglong Miao
Yinglong Miao
G protein-coupled receptors (GPCRs) are targets of extracellular stimuli and hence occupy a key position in drug discovery. By specific and not yet fully elucidated coupling profiles with α subunits of distinct G protein families, they regulate cellular responses. The histamine H2 and H4 receptors (H2R and H4R) are prominent members of Gs- and Gi-coupled GPCRs. Nevertheless, promiscuous G protein and selective Gi signaling have been reported for the H2R and H4R, respectively, the molecular mechanism of which remained unclear. Using a combination of cellular experimental assays and Gaussian accelerated molecular dynamics (GaMD) simulations, we investigated the coupling profiles of the H2R and H4R to engineered mini-G proteins (mG). We obtained coupling profiles of the mGs, mGsi, or mGsq proteins to the H2R and H4R from the mini-G protein recruitment assays using HEK293T cells. Compared to H2R–mGs expressing cells, histamine responses were weaker (pEC50, Emax) for H2R–mGsi and –mGsq. By contrast, the H4R selectively bound to mGsi. Similarly, in all-atom GaMD simulations, we observed a preferential binding of H2R to mGs and H4R to mGsi revealed by the structural flexibility and free energy landscapes of the complexes. Although the mG α5 helices were consistently located within the HR binding cavity, alternative binding orientations were detected in the complexes. Due to the specific residue interactions, all mG α5 helices of the H2R complexes adopted the Gs-like orientation toward the receptor transmembrane (TM) 6 domain, whereas in H4R complexes, only mGsi was in the Gi-like orientation toward TM2, which was in agreement with Gs- and Gi-coupled GPCRs structures resolved by X-ray/cryo-EM. These cellular and molecular insights support (patho)physiological profiles of the histamine receptors, especially the hitherto little studied H2R function in the brain, as well as of the pharmacological potential of H4R selective drugs.

1 March 2021 in European Journal of Medicinal Chemistry
Verified
Journal Article
Closed access
CWCorinna. G. Weinhart
Corinna. G. Weinhart
DWDavid Wifling
David Wifling
MSMaximilian. F. Schmidt
Maximilian. F. Schmidt
ENEduard Neu
Eduard Neu
Carina HöringCarina Höring
Carina Höring
MKMax Keller
Max Keller

3 June 2024 in bioRxiv
Verified
Preprint
Open access
PDF file
LHLaura J. Humphrys
Laura J. Humphrys
Carina HöringCarina Höring
Carina Höring
AGAlbert O. Gattor
Albert O. Gattor
HEK293 cells are a common immortal cell line used in biological research, and their popularity has led to different distinct lineages across the world. Commonly used for overexpression of proteins, HEK293 cells also natively express biological targets, such as G protein coupled receptors (GPCRs) and their downstream signalling partners, G proteins, although this often confounds rather than compliments research. CRISPR/Cas9 gene editing can be used to harness these native proteins and make use of their presence. Here, a cost- and time-effective, plasmid-based CRISPR/Cas9 approach is used to tag well-characterised GPCRS – the β-adrenoceptors 1 and 2 – with one part of a split Nanoluciferase and replace the G αs coupling partner with the complimentarily tagged minimal G s protein in HEK293T cells. Compared to untagged proteins, the CRISPR/Cas9 cells allow for better selective-ligand characterisation at the native β-adrenoceptors. Overexpressed tagged systems produce similar results to the CRISPR/Cas9 cells, however subtle changes in the characterisation of partial agonists, such as salbutamol, demonstrate the potential for utilising tagged native receptors in analysing biological effectors. Summary Statement: For the first time, a split-luciferase tagged minimal Gs protein and β 1 AR is inserted under endogenous promotors in HEK293T cells using CRISPR/Cas9 gene modification, avoiding protein overexpression in the assay.

20 April 2020 in The FASEB Journal
Verified
Journal Article
Open access
PDF file
Carina HöringCarina Höring
Carina Höring
USUlla Seibel
Ulla Seibel
TLTimo Littmann
Timo Littmann
LGLukas Graetz
Lukas Graetz
ASAndrea Strasser
Andrea Strasser
GBGuenther Bernhardt
Guenther Bernhardt
In addition to the determination of binding affinities, the functional characterization of biologically active compounds is a prerequisite in drug discovery in order to identify lead structures and to optimize potential scaffolds regarding their mode of action and potency. Therefore, our aim was to develop a high‐throughput screening (HTS) compatible assay procedure yielding functional parameters of histamine receptor ligands at a proximal level avoiding signal amplification. For this purpose, we applied the NanoLuc split‐luciferase technology to the histamine receptor subtypes H 1 , H 2 , H 3 and H 4 and the corresponding G protein surrogates miniG q , miniG s and miniG i . The small fragment of the NanoLuc (NlucC) was fused to the C‐terminus of the respective receptor to retain the integrity of the receptors regarding binding affinities and intracellular signalling, whereas the large fragment of the NanoLuc (NlucN) was N‐terminally fused to the miniG proteins (see fig. ). Upon activation by a ligand the corresponding miniG protein is recruited to the receptor which then leads to the formation of a functional NanoLuc enzyme enabling the registration of a concentration dependent luminescence signal (see fig. ). Compared to reported data, standard ligands for histamine receptors provide appropriate potencies, intrinsic activities and modes of action .By radioligand saturation binding experiments it could be shown that there was no alteration in the binding affinities of the radioligands due to the minor receptor modification by the C‐terminally fused NlucC. Additionally, this assay principle should be appropriate for HTS assessed by the investigation of the Z′ factor, which was in an excellent range for all histamine receptor subtypes (0.5 < Z′ < 1). From these results we conclude that the application of the presented methodology is an excellent approach to be implemented in routine and detailed functional characterisation of putative histamine receptor ligands synthesized in our group. Moreover, the assay offers an opportunity to draw conclusions on biased signalling of investigated ligands in combination with the results obtained in β‐arrestin recruitment assays . Support or Funding Information: This project is funded by the DFG research training group GRK1910. Schematic illustration of the assay principle. Two complementing NanoLuc fragments fused to the receptor and the mini G protein form a functional NanoLuc upon activation of the GPCR. Figure 1